Lyell Immunopharma, Inc.

Q4 2023 13F Holders

Symbol: LYEL
CUSIP: 55083R104
Type: Equity
Class: COM
Num filings: 125
Total reported value, excl. options: $258 M

Compare 2023 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type